Multiple Sclerosis Article

Article Summary:

CBD, short for cannabidiol, is a component of marijuana distinct from THC, the compound responsible for the psychoactive effects. While not FDA-approved for multiple sclerosis (MS), ongoing studies suggest potential benefits for symptoms like fatigue, pain, inflammation, depression, muscle stiffness, and mobility issues. CBD interacts with receptors in the central nervous system, possibly alleviating inflammation and modulating immune responses.

CBD is available in various forms, including foods, drinks, supplements (capsules, sprays, oils), and topical products. CBD oil is popular, administered orally or topically. Research indicates that sublingual sprays may be effective for MS. However, the FDA doesn’t regulate CBD supplements, leading to inconsistencies in purity and potency.

Daily doses up to 1500 milligrams are generally well-tolerated, with some individuals using 2.5-milligram sublingual sprays for up to two weeks. Potential side effects include dry mouth, diarrhea, reduced appetite, drowsiness, fatigue, irritability, lightheadedness, low blood pressure, and liver damage. Fat-rich foods can increase CBD absorption, potentially intensifying side effects. Additionally, CBD may interact with medications like blood thinners, necessitating consultation with a doctor before use.